Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Onyx

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Onyx's 2012 oncology sales performance.

Onyx Pharmaceuticals, Inc.

Dr Sunita Zalani joins Intarcia Therapeutics as regulatory head

Dr Sunita Zalani joins Intarcia Therapeutics as regulatory head She joins the company from Amgen's Onyx Pharmaceuticals subsiary, where she served as vice president of global regulatory affairs. ... Dr Zalani had been with Onyx - which was acquired by Amgen last year - since 2004 and prior to that worked at Lilly as

Amgen closes on second-line use for Kyprolis

Amgen closes on second-line use for Kyprolis Kyprolis - which was acquired by Amgen as part of its purchase of Onyx last year for $10.4bn, is already enjoying fairly buoyant growth in its current third-line multiple myeloma ... Amgen and Onyx are also developing a once-weekly formulation that would

Amgen cuts workforce and facilities despite profit leap

Amgen cuts workforce and facilities despite profit leap grew 7 per cent to $1.2bn - and last year's $10.4bn acquisition of Onyx which added myeloma therapy Kyprolis (carfilzomib).

Nexavar fails late-stage breast cancer trial

Nexavar fails late-stage breast cancer trial Efforts by Bayer and Amgen subsidiary Onyx to expand the indications of their cancer drug Nexavar into breast cancer have hit the buffers. ... Bayer, Onyx and their clinical partners also have phase III trials of Nexavar ongoing in adjuvant (post-surgery)

Onyx launches women’s health blog

Onyx launches women’s health blog PR firm aims to understand women’s attitudes towards their health. Healthcare PR agency Onyx has launched a women's health blog to better understand women's attitudes towards their health.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...
Is communication failing us?
Compelling people to care in a world oversaturated with news and information...